Allosteric Modulation of GCase Enhances Lysosomal Activity and Reduces ER Stress in GCase-Related Disorders
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094392 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ilaria Fregno und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università Della Svizzera Italiana, CH-6500 Bellinzona, Switzerland. Hauptthemen laut MEDLINE: Lysosomes, Glucosylceramidase, Endoplasmic Reticulum Stress, Gaucher Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eurostars-2 joint program with co-funding from the European Union Horizon 2020 Research and Innosuisse - Swiss Innovation Agency, Swiss National Science Foundation, Eurostars-2 joint program.
Abstract (Originalsprache)
Variants in the GBA1 gene, encoding the lysosomal enzyme glucosylceramidase beta 1 (GCase), are linked to Parkinson’s disease (PD) and Gaucher disease (GD). Heterozygous variants increase PD risk, while homozygous variants lead to GD, a lysosomal storage disorder. Some GBA1 variants impair GCase maturation in the endoplasmic reticulum, blocking lysosomal transport and causing glucosylceramide accumulation, which disrupts lysosomal function. This study explores therapeutic strategies to address these dysfunctions. Using Site-directed Enzyme Enhancement Therapy (SEE-Tx®), two structurally targeted allosteric regulators (STARs), GT-02287 and GT-02329, were developed and tested in GD patient-derived fibroblasts with relevant GCase variants. Treatment with GT-02287 and GT-02329 improved the folding of mutant GCase, protected the GCaseLeu444Pro variant from degradation, and facilitated the delivery of active GCase to lysosomes. This enhanced lysosomal function and reduced cellular stress. These findings validate the STARs’ mechanism of action and highlight their therapeutic potential for GCase-related disorders, including GD, PD, and Dementia with Lewy Bodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biomedical Sciences, Institute for Research in Biomedicine, Università Della Svizzera Italiana, CH-6500 Bellinzona, Switzerland.
- Gain Therapeutics, Sucursal en España, Parc Científic de Barcelona, 08028 Barcelona, Spain.
- Department of Biology, Swiss Federal Institute of Technology; CH-8093 Zurich, Switzerland.
- GT Gain Therapeutics SA, CH-6900 Lugano, Switzerland.
- School of Life Sciences, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
ORCID-Profile: Mikhail Rudinskiy, Aida Delgado, Elena Cubero, Ana María García-Collazo, Maurizio Molinari
Förderung
- Eurostars-2 joint program with co-funding from the European Union Horizon 2020 Research and Innosuisse - Swiss Innovation Agency
- Swiss National Science Foundation
- Eurostars-2 joint program
Zitieren
APA
Fregno, I., Pérez-Carmona, N., Rudinskiy, M., Soldà, T., Bergmann, T. J., Ruano, A., Delgado, A., Cubero, E., Bellotto, M., García-Collazo, A. M., & Molinari, M. (2025). Allosteric Modulation of GCase Enhances Lysosomal Activity and Reduces ER Stress in GCase-Related Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094392
Vancouver
Fregno I, Pérez-Carmona N, Rudinskiy M, Soldà T, Bergmann TJ, Ruano A, et al. Allosteric Modulation of GCase Enhances Lysosomal Activity and Reduces ER Stress in GCase-Related Disorders. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094392
BibTeX
@article{Fregno2025,
author = {Fregno, Ilaria and Pérez-Carmona, Natalia and Rudinskiy, Mikhail and Soldà, Tatiana and Bergmann, Timothy J and Ruano, Ana and Delgado, Aida and Cubero, Elena and Bellotto, Manolo and García-Collazo, Ana María and Molinari, Maurizio},
title = {Allosteric Modulation of GCase Enhances Lysosomal Activity and Reduces ER Stress in GCase-Related Disorders},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094392}
}
EUVIMED